Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
Sorry - I responded to this before.
This is a process for delisted shares - this isn't appropriate now that they are listed again and shares were admitted.
This is for delisted stocks, they clearly haven't got the memo that these shares have been re-admitted to AIM.
Search 'SOP' or Spinnaker Spinnaker / Opportunities PLC
The company RTO'd into this old ticker, many platforms will let you trade SOP until they update to KNB. 'Just bought 25k at 16.8.
I don’t know who needs to see this but reading posts about Surescreen.
Surescreen have SOLD tests to the UK Gov and will have a large contract. Omega have sold Manufacturing Capacity to the government, not complete tests and thus their Contract even to manufacture say 33m tests will be significantly smaller.
Omega is a manufacturing contractor, the needle has moved slightly from when they planned to sell tests directly.
I can buy £50k right now at 87p on HL - if there was huge demand the price would be going up.
People who were anticipating 100% on that RNS are very naive. I have been an open critic of ODX but think they have done well to navigate around the ABc19 saga and deliver their capacity in another way.
This ‘news’ was leaked last weekend and has taken you from 67p to 100p already - a further 20% today.
To those of you complaining, should have been in earlier. I don’t hold by the way.
Not invested here, however looking at the price action live it looks like there is a very large buyer at 127p
CIGA Have provided pricing to me for ABC-19 tests.
Orders over 1000x units £6/unit
Orders under 1000x units £8/unit
Hi Folks,
I just received an email from Lyndsay Lynch at CIGA telling me that they are now ready to take orders for the ABC-19 antibody test.
Looks like free to pruchase.
Tom
Eurgh, disappointing
That's put a smile on my face before the weekend - looks like an insti loading up. Hope you all held on.
Calling BS on that price
I must admit I am a bit annoyed with the tweeting coming out of PrimerDesign.
I appreciate that they have hired a 'researcher' who was very popular on Twitter - but find some of the tweets quite unprofessional for an aspiring midcap diagnostics company - using a bunch of tongue out emoji's and innuendo.
Don't read too much into the tweets, is all I'm saying. I think it's more an informal way of saying 'You aint seen nothin' yet'.
Price action disappointing but will hold regardless - wish I had some topup funds.
Big pharmacy be rubbing their hands with glee
Serious holders would do well to be reminded of the initial DHSC contract.
Contract news did nothing for SP on the day but over the next 7 days there were compound gains.
I will hold and watch it play out.
Back down to earth - let’s not forget last night was a major vaccine announcement across the world.
You may find that the results take a few days to bed in, before pushing up to 30/40/50% over the coming week
Interesting day for sure - will Deloitte be announcing their takeover of ODX ? [/sarcasm]
Find me another business on AIM with a serious revenue - that can make this statement:
‘ Gross margin for the full year above 80% ‘ - seriously, unbelievable.
Highlights
· Revenue for the full year of 2020 increased by over 20x to €311.6 million (£277.0 million) compared to €13.1 million (£11.5 million) for the full year of 2019
· Revenue of €239.2 million (£213.7 million) delivered in H2 2020 compared to €72.4 million (£63.3 million) in H1 2020
· Gross margin for the full year above 80%
· EBITDA profitability for the full year above €210 million (£187 million), with H2 2020 EBITDA above €161 million (£143 million) compared to €49.4 million (£43 million) in H1 2020
· The Company's cash position at 31 December 2020 was €101 million (£91.8 million), compared to €1.8 million (£1.6 million) at 31 December 2019 and €19.7 million (£18.0 million) at 30 June 2020
· Investment in pipeline of next generation COVID-19 tests to address evolving clinical needs
· Acquisition of IT-IS International, a profitable diagnostic instrument development and manufacturing company, in line with strategy
Eek.... disappointment perhaps